Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Fennessy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|January 10, 2001
Can tea tree (Melaleuca alternifolia) oil prevent MRSA?J N Anderson, P A Fennessy
Respiration Physiology|September 1, 1975
Nitrogen exchange across the lungs in resting manP A Fennessy, M H Harrison, C Davison
Atherosclerosis|March 1, 1994
Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in cultureP A Fennessy, J H Campbell, G R Campbell
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|January 1, 1978
Intravascular volume and tonicity as factors in the regulation of body temperatureM H Harrison, R J Edwards, P A Fennessy
Clinical Science (London, England : 1979)|December 1, 1994
An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbitP A Fennessy, J H Campbell, G R Campbell
The American Journal of Physiology|March 1, 1992
Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruliK M Denton, P A Fennessy, D Alcorn, et al.
Clinical and Experimental Pharmacology & Physiology|August 1, 1996
Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human diseaseP A Fennessy, J H Campbell, F A Mendelsohn, et al.
BMC Medical Informatics and Decision Making|November 22, 2001
Improving question formulation for use in evidence appraisal in a tertiary care setting: a randomised controlled trial [ISRCTN66375463]E V Villanueva, E A Burrows, P A Fennessy, et al.
Pharmacological Research|September 1, 1996
Short-term and long-term cardiovascular actions of different doses of perindopril in the rabbitP A Fennessy, S Godwin, G A Head, et al.
The Medical Journal of Australia|May 19, 2000
"Picking winners": assessing new health technologyJ N Anderson, P A Fennessy, G A Fennessy, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|January 10, 2001
Can tea tree (Melaleuca alternifolia) oil prevent MRSA?J N Anderson, P A Fennessy
Respiration Physiology|September 1, 1975
Nitrogen exchange across the lungs in resting manP A Fennessy, M H Harrison, C Davison
Atherosclerosis|March 1, 1994
Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in cultureP A Fennessy, J H Campbell, G R Campbell
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|January 1, 1978
Intravascular volume and tonicity as factors in the regulation of body temperatureM H Harrison, R J Edwards, P A Fennessy
Clinical Science (London, England : 1979)|December 1, 1994
An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbitP A Fennessy, J H Campbell, G R Campbell
The American Journal of Physiology|March 1, 1992
Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruliK M Denton, P A Fennessy, D Alcorn, et al.
Clinical and Experimental Pharmacology & Physiology|August 1, 1996
Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human diseaseP A Fennessy, J H Campbell, F A Mendelsohn, et al.
BMC Medical Informatics and Decision Making|November 22, 2001
Improving question formulation for use in evidence appraisal in a tertiary care setting: a randomised controlled trial [ISRCTN66375463]E V Villanueva, E A Burrows, P A Fennessy, et al.
Pharmacological Research|September 1, 1996
Short-term and long-term cardiovascular actions of different doses of perindopril in the rabbitP A Fennessy, S Godwin, G A Head, et al.
The Medical Journal of Australia|May 19, 2000
"Picking winners": assessing new health technologyJ N Anderson, P A Fennessy, G A Fennessy, et al.
Pageof 2